Trending Now
AutoWeb Inc. (NASDAQ: AUTO) Acquires CarZeus Assets to Its Grow Marketing...
AutoWeb Inc. (NASDAQ: AUTO) has purchased san Antonio, Texas-based CarZeus’ assets. CarZeus is a used car acquisition platform that buys cars from customers and...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Synaptogenix Inc (NASDAQ: SNPX) Announces a Peer-reviewed Paper on Bryostatin
Synaptogenix Inc (NASDAQ: SNPX) announced a peer-reviewed paper published in the Frontiers Aging Neuroscience. The paper came from a collaboration between the company’s Chief...
MAKE IT MODERN
LATEST REVIEWS
Dyne Therapeutics Inc. (NASDAQ: DYN) Receives Clinical Hold From FDA...
Dyne Therapeutics Inc. (NASDAQ: DYN) has announced that the US FDA has put a clinical hold on its Investigational New Drug application...
MAKE IT MODERN
PERFORMANCE TRAINING
AIM ImmunoTech (NYSEAMERICAN:AIM) Receives IRB Approval For Enrolment Of COVID-19-Induced Fatigue Patients In Ampligen...
AIM ImmunoTech Inc. (NYSEAMERICAN:AIM) has announced the receipt of an Institutional Review Board Approval for expansion of the AMP-511 Expanded Access Program clinical study...
Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) Receive Approval From European Commission For Expanded KALYDECO® Label
Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) has announced that it has received approval from the EU for KALYDECO® granules label extension. The extension includes treatment of...
Health Department Urges DEA to Reevaluate Marijuana Restrictions (TLRY,ACB,CURLF,CGC)
Last week saw the Department of Health and Human Services (HHS) nudging the Drug Enforcement Agency (DEA) to reconsider the stringent constraints...
Altimmune Inc. (NASDAQ:ALT) Submits Investigational New Drug Application for AdCOVID™ COVID-19 Vaccines
Altimmune Inc. (NASDAQ:ALT) has submitted an Investigational New Drug (IND) application to the FDA for the commencement of Phase 1 clinical study...
Pharmacyte Biotech, Inc. (NASDAQ: PMCB) Reports The First Test Results Of The Biocompatibility Studies...
Several studies are currently ongoing by independent, third-party CROs. And according to Kenneth L. Waggoner, the CEO of PharmaCyte Biotech, Inc. (NASDAQ: PMCB), the...
MAKE IT MODERN
